Medicine
Normosol-m And Dextrose 50 g/210 mg/1280 mg/2340 mg per 1000 mL injection
Normosol-m And Dextrose 50 g/210 mg/1280 mg/2340 mg per 1000 mL injection is a prescription medicine containing Dextrose, Magnesium acetate, Potassium acetate and Sodium chloride for intravenous use, marketed by ICU Medical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 to 25°C (68 to 77°F).
Key facts
- Active ingredient (INN)
- Dextrose, Magnesium acetate, Potassium acetate and Sodium chloride
- Brand
- Normosol-m And Dextrose
- Strength
- 50 g/210 mg/1280 mg/2340 mg per 1000 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 12 pouches of 1000 mL
- Marketing authorisation holder
- ICU Medical
- Manufacturer
- ICU Medical
- Origin register
- US FDA, United States
- Storage
- Store at 20 to 25°C (68 to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 February 2021
- Identifiers
- RxCUI 801005, 801009DailyMed set ID aba60c84-94d9-46d0-bdbb-25e0c4e8cc41NDC 0990-7965Application NDA017610
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 pouch in 1 case / 1 bag in 1 pouch / 1000 mL in 1 bag | 0990-7965-09 | ICU Medical | 8 February 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 13 August 1975 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Dextrose, Magnesium acetate, Potassium acetate and Sodium chloride is a fixed-dose combination of an osmotic laxative, a calculi dissolution agent and a potassium salt. MedsAcross supplies Dextrose, Magnesium acetate, Potassium acetate and Sodium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Dextrose, Magnesium acetate, Potassium acetate and Sodium chlorideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NORMOSOL-M AND DEXTROSE prescribing information (ICU Medical) · U.S. National Library of Medicine, DailyMed
Need Normosol-m And Dextrose 50 g/210 mg/1280 mg/2340 mg per 1000 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.